TDA
what evidence is there that there is an oncology market for HyACT?
To quote from the website:
"Because initial HyACTproducts will consist of two already approved substances (a cancer drug with HA), they should offer a lower risk route to valuable new pharmaceutical formulations.."
So the strategy is simple. Talk to every major oncology player and validate that they want it.
Have they done this? have we been told they've done this?
If there is clear evidence that big Oncology wants, needs and is desperate for HyACT, I am in. However, there is no evidence that this is the case. No evidence that Shareholders can use to assess whether this is worth something or is simply a way a bunch of scientists can ensure that they get paid whopping great big salaries developing a technology no one wants.
TDA and others, if you have evidence then let us know. I have been waiting on the sidelines for a while. Watching my existing holding getting belted and now diluted. Make me a believer, go on!
Em
- Forums
- ASX - By Stock
- TSN
- 1-2 mill per month
1-2 mill per month, page-34
-
- There are more pages in this discussion • 35 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add TSN (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.409M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
TSN (ASX) Chart |
Day chart unavailable
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online